Who owns Stoke Therapeutics Inc?
- Ticker: STOK
- CUSIP Number: 86150r107
Tip: Access positions for across all investors
Analyze quarterly positions in Stoke Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Stoke Therapeutics stock
Who bought or sold Stoke Therapeutics Inc this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Skorpios Trust | 14M | $76M | 0% | Dec 2023 |
|
| Cowen And Company | 3.7M | $20M | 0% | Dec 2023 |
|
| Lynx1 Capital Management | 3.0M | $16M | 73% | Dec 2023 |
|
| Redmile Group | 2.6M | $14M | -32% | Dec 2023 |
|
| Baker Bros. Advisors | 2.0M | $11M | 37% | Dec 2023 |
|
| Vanguard Group | 1.6M | $8.7M | 1% | Dec 2023 |
|
| Goldman Sachs Group | 1.4M | $7.3M | 976% | Dec 2023 |
|
| Cormorant Asset Management | 1.1M | $5.7M | 0% | Dec 2023 |
|
| Deutsche Bank Aktiengesellschaft | 413k | $2.2M | 2899% | Dec 2023 |
|
| Healthcare Of Ontario Pension Plan Trust Fund | 239k | $1.3M | 0% | Dec 2023 |
|
| Dimensional Fund Advisors | 215k | $1.1M | -17% | Dec 2023 |
|
| Charles Schwab Investment Management | 205k | $1.1M | -6% | Dec 2023 |
|
| Jacobs Levy Equity Management | 168k | $884k | -23% | Dec 2023 |
|
| D. E. Shaw & Co | 143k | $751k | -30% | Dec 2023 |
|
| GSA Capital Partners | 102k | $537k | -71% | Dec 2023 |
|
| Bank of New York Mellon | 98k | $517k | -8% | Dec 2023 |
|
| State of Wisconsin Investment Board | 87k | $456k | 9% | Dec 2023 |
|
| Fort Point Capital Partners | 75k | $397k | 0% | Dec 2023 |
|
| Bank of America Corporation | 75k | $396k | 31% | Dec 2023 |
|
| Thomas Stevens, CFA" | 62k | $841k | 0% | Mar 2024 |
|
| Gilder, Gagnon, Howe & Co | 62k | $327k | 0% | Dec 2023 |
|
| Jane Street | 51k | $267k | 100% | Dec 2023 |
|
| Rhumbline Advisers | 41k | $216k | 0% | Dec 2023 |
|
| Trexquant Investment | 40k | $209k | -69% | Dec 2023 |
|
| Barclays | 39k | $206k | 365% | Dec 2023 |
|
| Alliancebernstein | 37k | $196k | -10% | Dec 2023 |
|
| Seven Grand Managers | 30k | $405k | 100% | Mar 2024 |
|
| T. Rowe Price Associates | 30k | $157k | 0% | Dec 2023 |
|
| UBS Group | 30k | $157k | 47% | Dec 2023 |
|
| Millennium Management | 24k | $126k | -91% | Dec 2023 |
|
| Squarepoint Ops | 19k | $100k | 26% | Dec 2023 |
|
| Jpmorgan Chase & Co | 18k | $95k | -32% | Dec 2023 |
|
| Ohio Pers | 17k | $91k | 6% | Dec 2023 |
|
| Citadel Advisors | 17k | $90k | -79% | Dec 2023 |
|
| Man Group | 15k | $81k | -86% | Dec 2023 |
|
| SG Americas Securities | 15k | $79k | 11% | Dec 2023 |
|
| MetLife Investment Advisors | 15k | $77k | 0% | Dec 2023 |
|
| Zacks Investment Management | 14k | $74k | 100% | Dec 2023 |
|
| American International | 14k | $72k | 0% | Dec 2023 |
|
| Algert Coldiron Investors | 13k | $66k | -24% | Dec 2023 |
|
| Ikarian Capital | 12k | $64k | -4% | Dec 2023 |
|
| Principal Financial Group | 12k | $63k | -1% | Dec 2023 |
|
| Two Sigma Investments | 11k | $59k | -60% | Dec 2023 |
|
| Two Sigma Advisers | 11k | $58k | -20% | Dec 2023 |
|
| Dorsey & Whitney Trust Company | 11k | $57k | 0% | Dec 2023 |
|
| New York State Common Retirement Fund | 11k | $56k | 0% | Dec 2023 |
|
| Wells Fargo & Company | 8.5k | $45k | 25% | Dec 2023 |
|
| Bnp Paribas Arbitrage, Snc | 7.7k | $41k | -73% | Dec 2023 |
|
| Royal Bank of Canada | 7.5k | $41k | 63% | Dec 2023 |
|
| Lazard Asset Management | 5.8k | $0 | 4% | Dec 2023 |
|
| Citigroup | 4.0k | $20k | 562% | Dec 2023 |
|
| Cutler | 3.3k | $1.2k | 200% | Mar 2024 |
|
| Legal & General Group | 3.1k | $17k | -71% | Dec 2023 |
|
| Summit Investment Advisors | 2.3k | $12k | 0% | Dec 2023 |
|
| NISA Investment Advisors | 1.9k | $10k | 2875% | Dec 2023 |
|
| Metropolitan Life Insurance Company | 1.5k | $8.0k | 0% | Dec 2023 |
|
| Simplex Trading | 1.2k | $15k | -86% | Mar 2024 |
|
| Amalgamated Bank | 787.00 | $11k | -63% | Mar 2024 |
|
| Provence Wealth Management Group | 470.00 | $2.5k | 0% | Dec 2023 |
|
| GAMMA Investing | 117.00 | $1.6k | 100% | Mar 2024 |
|
| Pnc Financial Services | 5.00 | $26.000000 | 100% | Dec 2023 |
|
Who sold out of Stoke Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Wellington Management Company | Sep 2023 | 174k | $687k |
| Mirae Asset Global Investments | Sep 2023 | 146k | $576k |
| Simplify Asset Management | Sep 2023 | 103k | $406k |
| Walleye Trading Advisors | Sep 2023 | 67k | $265k |
| Marshall Wace | Sep 2023 | 48k | $189k |
| Swiss National Bank | Sep 2023 | 43k | $171k |
| ALPS Advisors | Sep 2023 | 33k | $129k |
| Tudor Investment Corporation | Sep 2023 | 18k | $72k |
| Corton Capital | Sep 2023 | 15k | $58k |
| Credit Suisse | Sep 2023 | 12k | $49k |
| Sherbrooke Park Advisers | Sep 2023 | 12k | $48k |
| Ubs Global Asset Management Americas | Sep 2023 | 11k | $45k |
| Virtus ETF Advisers | Sep 2023 | 7.9k | $31k |
| China Universal Asset Management | Sep 2023 | 1.1k | $4.0k |
| Federated Investors | Sep 2023 | 1.1k | $4.2k |
| Us Bancorp | Sep 2023 | 538.00 | $2.1k |
| Quadrant Capital | Sep 2023 | 221.00 | $871.005200 |
| Daiwa Securities Group | Sep 2023 | 126.00 | $0 |
| Beaird Harris Wealth Management | Sep 2023 | 38.00 | $150.001200 |